Incuron   Report issue

For profit Phase 2
Founded: Moscow Russian Federation (2009)

Organization Overview

First Clinical Trial
2013
NCT01905228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Incuron | Incuron LLC